The Plaintiff Seylynn (North Shore) Development Limited Partnership (“Seylynn LP”) and the Defendants to the Counterclaim Seylynn (North Shore) Properties Phase II Limited Partnership, Denna Development Corp., and Denna Properties Corp. (“Seylynn Group”), brought a motion in writing for an order that the Defendant/Plaintiff by Counterclaim, Abo Taheri (“Taheri”), serve and file an accurate and complete Affidavit of Documents.

The Defendants moved for an order to compel the Plaintiff to provide answers to certain discovery questions and to strike the statements of defence to counterclaim of Ms. Wan Ling Leung and Mr. Edbert Joaquin. The Court resolved issues regarding outstanding answers with reasons given at the hearing, while the issue of striking the pleading was reserved.

Playtika Ltd., Caesars Interactive Entertainment LLC and Playtika (Canada) Inc. (the Defendants) brought a motion for summary trial in the context of a trademark expungement and passing off action brought by Enigmatus s.r.o. (the Plaintiff).

The Protective Order in this proceeding allows a party to designate information it is disclosing as “Confidential Information” or “Solicitor’s Eyes Only Information.” The proper interpretation of the provision setting out the test to be met to allow a disclosing party to make this designation was in dispute between the parties. The Order allowed a challenge to the designation, and stated that the burden, based on a balance of probabilities, is on the party asserting confidentiality.

This order stems from Indigo’s motion to require Charge to post $30,000 in security, pursuant to Federal Courts Rules 369, 415 and 416, for anticipated costs for defending Charge’s counterclaim.

Guangzhou Wanglaoji Grand Health Co, Ltd (Wanglaoji) appealed the decision of the Registrar of Trademarks (Registrar) in summary cancellation proceedings under s. 45 of the Trademarks Act (TMA) regarding Multi Access Limited’s (MAL) registered trademarks.

In November 2017, Panthera filed a trademark application for the PANTHERA logo. On November 27, 2019, Jaguar filed a statement opposing Panthera’s registration application.

This Judgment and Reasons dealt with an application for judicial review brought by Galderma in respect of a decision by the Patented Medicines Prices Review Board (the “Board”) which found that the invention of Canadian Patent 2,478,237 pertained to, or could be used for, Galderma’s product DIFFERIN.

This was an appeal of a section 45 proceeding raised against three registered trademarks owned by Coors, related to the marketing of Miller High Life beer as “The Champagne of Beers.” Despite Coors not providing evidence of use, the Registrar of Trademarks maintained the registrations, finding that special circumstances excused non-use. The Federal Court upheld the Registrar’s finding.

The Defendant had a history of appointing lawyers and then not communicating with them, resulting in a succession of lawyers seeking to be removed from the record.